Business ❯ Manufacturing

Pharmaceutical Manufacturing

Investment Supply Chain Domestic Production Regulated Products Subsidies Pfizer Rocky Mountain Plant Vaccine Manufacturing Solvent Production Quality Assurance Supply Chain Management Custom Synthesis Production Relocation Production Facilities US Manufacturing Facilities Global Supply Chain U.S. Manufacturing Biopharma Sector Facility Construction US Manufacturing Policy U.S. Manufacturing Facilities Production Challenges Baxter International

Eli Lilly Builds $1.5 Billion Stockpile of Orforglipron as FDA Decision Nears

The $1.5 billion pre‑launch cache signals a bid to avoid past GLP‑1 supply gaps ahead of an expected spring FDA ruling on the once‑daily pill.

Eli Lilly Jumps on GLP‑1 Momentum as 2026 Outlook Beats and Targets Rise